Catherine Schulte
Stock Analyst at Baird
(4.03)
# 478
Out of 4,869 analysts
130
Total ratings
54.55%
Success rate
9.72%
Average return
Main Sectors:
Stocks Rated by Catherine Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Outperform | $159 → $140 | $115.56 | +21.15% | 16 | May 22, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $3 → $2 | $2.06 | -2.91% | 6 | May 13, 2025 | |
| EXAS Exact Sciences | Maintains: Outperform | $69 → $72 | $53.01 | +35.82% | 14 | May 2, 2025 | |
| AVTR Avantor | Maintains: Outperform | $21 → $17 | $13.57 | +25.28% | 11 | Apr 28, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $603 → $573 | $397.88 | +44.01% | 26 | Apr 24, 2025 | |
| DHR Danaher | Maintains: Outperform | $231 → $225 | $196.39 | +14.57% | 9 | Apr 23, 2025 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,369 → $1,034 | $1,153.93 | -10.39% | 8 | Apr 22, 2025 | |
| QGEN Qiagen | Maintains: Neutral | $42 → $43 | $46.76 | -8.04% | 4 | Apr 21, 2025 | |
| TECH Bio-Techne | Downgrades: Neutral | $88 → $68 | $49.89 | +36.30% | 11 | Feb 19, 2025 | |
| CSTL Castle Biosciences | Maintains: Outperform | $42 → $38 | $18.51 | +105.29% | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $56 → $33 | $34.64 | -4.73% | 3 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $335 → $281 | $90.49 | +210.53% | 7 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $208 → $217 | $342.63 | -36.67% | 7 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $171.86 | -88.36% | 1 | Jun 28, 2018 |
Agilent Technologies
May 22, 2025
Maintains: Outperform
Price Target: $159 → $140
Current: $115.56
Upside: +21.15%
Maravai LifeSciences Holdings
May 13, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $2.06
Upside: -2.91%
Exact Sciences
May 2, 2025
Maintains: Outperform
Price Target: $69 → $72
Current: $53.01
Upside: +35.82%
Avantor
Apr 28, 2025
Maintains: Outperform
Price Target: $21 → $17
Current: $13.57
Upside: +25.28%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $603 → $573
Current: $397.88
Upside: +44.01%
Danaher
Apr 23, 2025
Maintains: Outperform
Price Target: $231 → $225
Current: $196.39
Upside: +14.57%
Mettler-Toledo International
Apr 22, 2025
Maintains: Neutral
Price Target: $1,369 → $1,034
Current: $1,153.93
Upside: -10.39%
Qiagen
Apr 21, 2025
Maintains: Neutral
Price Target: $42 → $43
Current: $46.76
Upside: -8.04%
Bio-Techne
Feb 19, 2025
Downgrades: Neutral
Price Target: $88 → $68
Current: $49.89
Upside: +36.30%
Castle Biosciences
Mar 1, 2023
Maintains: Outperform
Price Target: $42 → $38
Current: $18.51
Upside: +105.29%
Nov 21, 2022
Maintains: Outperform
Price Target: $56 → $33
Current: $34.64
Upside: -4.73%
Sep 22, 2020
Maintains: Neutral
Price Target: $335 → $281
Current: $90.49
Upside: +210.53%
Oct 30, 2019
Maintains: Neutral
Price Target: $208 → $217
Current: $342.63
Upside: -36.67%
Jun 28, 2018
Maintains: Outperform
Price Target: $17 → $20
Current: $171.86
Upside: -88.36%